WEED Canopy Growth Corporation

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · canopygrowth.com

1.270CAD+0.79%Mkt Cap: 412.28M $P/E: —Today

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and …

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap412.28M USD

Enterprise Value344.14M USD

Revenue (TTM)213.84M USD

Gross Profit50.74M USD

Net Income (TTM)-191.47M USD

Revenue/Share0.82 CAD

Last Price1.270 CAD

Fiscal Year EndMar 2026

MR QuarterJun 2026

Employees1.1K

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA1380351009

Valuation

P/E (Trailing)—

P/E (Forward)-7.41

PEG—

EV/EBITDA-18.10

EV/Revenue1.61

P/S1.93

P/B0.77

EPS (TTM)-0.62

EPS (Forward)-0.17

52W Range

1.1804% of range3.280

52W High3.280 CAD

52W Low1.180 CAD

Profitability

Gross Margin24.48%

Oper. Margin-21.66%

EBITDA Margin-8.89%

Profit Margin-92.38%

ROE-37.69%

ROA-23.50%

Growth

Revenue Growth12.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-46.47M USD

CapEx (TTM)4.34M USD

FCF Margin2.45%

FCF Yield1.27%

Net Debt-44.04M USD

Net Debt/EBITDA2.32

Balance Sheet

Debt/Equity0.40

Current Ratio3.04

Quick Ratio2.28

Book Value/Sh1.63 CAD

Cash/Share0.80 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateDec 20, 2023

Analyst Consensus

Rating—

Target (Mean)2.020 CAD

Upside (mean)+59.1%

Target Range0.9400 CAD – 5.000 CAD

0.9400+59.1% to mean5.000

# Analysts7

Ownership

Shares Out.423.04M

Float422.10M

Insiders0.19%

Institutions7.99%

Short Interest

Short Ratio24.2d

Short % Float3.86%

Short % Out.3.86%

Shares Short16.34M

Short (prev mo.)16.51M

Technical

SMA 501.341 (-5.3%)

SMA 2001.472 (-13.7%)

Beta2.43

S&P 52W Chg14.58%

Avg Vol (30d)636.39K

Avg Vol (10d)630.13K

Technical Indicators

RSI (14)40.4

MACD-0.0193

MACD Signal-0.0134

MACD Hist.-0.0059

BB Upper1.376 CAD

BB Middle1.310 CAD

BB Lower1.245 CAD

BB Width9.93%

ATR (14)0.0428 CAD

Vol Ratio (20d)0.74x